AvKARE Recalls Fludrocortisone Acetate Tablets Due to Impurity Failures
AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets, USP 0.1mg, because the product failed impurities and degradation specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to failed impurities and degradation specifications. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets, USP 0.1mg, NDC 50268-330-15. The recall was initiated because the product failed impurities and degradation specifications.
The affected product is Lot # 48353 with an expiration date of 10/31/2026. The tablets are packaged in 50-tablet unit dose AVPAKs and were distributed nationwide in the United States.
Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for a replacement or further instructions.
The recalled product
- Product
- FLUDROCORTISONE ACETATE (FLUDROCORTISONE ACETATE)
- Brand
- FLUDROCORTISONE ACETATE
- Manufacturer
- AvKARE
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 8,866
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 48353
- Exp. 10/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · AvKARE
See all →- HighAmantadine hydrochloride capsules recalled after failing dissolution specifications
FDA (Drugs) · 2026-03-04
- ModerateRosuvastatin tablets recalled after failing a dissolution specification
FDA (Drugs) · 2026-01-14
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighAvKare chlorpromazine 100 mg cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
- HighAvKare chlorpromazine unit dose cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
Same hazard · impurities
See all →- ModerateHuons Carboxymethylcellulose Sodium Eye Drops Recalled for Impurities
FDA (Drugs) · 2026-11-04
- ModerateRitedose Recalls Formoterol Fumarate Inhalation Solution Due to Impurities
FDA (Drugs) · 2026-11-04
- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Specifications
FDA (Drugs) · 2026-10-14
Similar recalls
- ModerateAvKARE Recalls Famciclovir Tablets Due to Impurity Levels
FDA (Drugs) · 2017-03-29
- High
- SevereAvKARE Recalls Losartan Potassium Tablets Due to Impurity
FDA (Drugs) · 2019-05-08
- HighGlycopyrrolate 1 mg Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-01-04
- ModerateAvKARE Recalls Voriconazole Tablets Due to Impurity Specification Failure
FDA (Drugs) · 2017-08-23
- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16